NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
55 hedge funds and large institutions have $13.3M invested in Navidea Biopharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
91% less call options, than puts
Call options by funds: $10K | Put options by funds: $116K
Holders
55
Holding in Top 10
–
Calls
$10K
Puts
$116K
Top Buyers
| 1 | +$1.34M | |
| 2 | +$215K | |
| 3 | +$150K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$50.4K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$46K |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$339K | |
| 3 | -$297K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$233K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$217K |